ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

ONS Meeting Again With ASCO And AACR In San Francisco

April 28, 1989

In Brief: GSA Sitting On Breast Cancer Tapes; Creech, Owens Names President-Elect Of AACR, ASCO

May 27, 1977

ZBB Considered Useless By NCI Staff (Privately)’ New Approach Groups Program Into Four Categories

October 6, 1978

NCI’s SBIR Paylines Nears Regular Grants

September 20, 1985

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

October 20, 1995

Commemoration Planned For Heidelberger

February 11, 1983